Anti-BCMA/CD70 CAR-T cells is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. The lead sponsor is The Children's Hospital of Zhejiang University School of Medicine. Registered phase: Phase 1. Conditions studied include Multi-Drug Resistant Nephrotic Syndrome; CAR-T Cell Therapy; CAR T Cell Therapy.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06553898 | Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS (ClinicalTrials.gov ↗) Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy |
Phase 1 | Recruiting |
| NCT06934447 | Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE (ClinicalTrials.gov ↗) CAR T Cell Therapy, Systemic Lupus Erythematosus, BCMA |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Multi-Drug Resistant Nephrotic Syndrome | 1 |
| CAR-T Cell Therapy | 1 |
| CAR T Cell Therapy | 1 |
| Systemic Lupus Erythematosus | 1 |
| BCMA | 1 |
| Lead sponsor | Trials |
|---|---|
| The Children's Hospital of Zhejiang University School of Medicine | 2 |
| Register | Anti-BCMA/CD70 CAR-T cells trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Anti-BCMA/CD70 CAR-T cells works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Anti-BCMA/CD70 CAR-T cells (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.